Titlebook: Organotypic Models in Drug Development; Monika Sch?fer-Korting,Silvya Stuchi Maria-Engler, Book 2021 Springer Nature Switzerland AG 2021 o

全體

書目名稱Organotypic Models in Drug Development影響因子(影響力)




書目名稱Organotypic Models in Drug Development影響因子(影響力)學(xué)科排名




書目名稱Organotypic Models in Drug Development網(wǎng)絡(luò)公開度




書目名稱Organotypic Models in Drug Development網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Organotypic Models in Drug Development被引頻次




書目名稱Organotypic Models in Drug Development被引頻次學(xué)科排名




書目名稱Organotypic Models in Drug Development年度引用




書目名稱Organotypic Models in Drug Development年度引用學(xué)科排名




書目名稱Organotypic Models in Drug Development讀者反饋




書目名稱Organotypic Models in Drug Development讀者反饋學(xué)科排名

convert

帶來墨水

0171-2004 he research on human-based test systems has gained major interest and funding in the EU and the US has increased over the last years. Moreover, so-called 3R (reduce, replace, refine animal experiments) centres have been established worldwide.?.978-3-030-70065-2978-3-030-70063-8Series ISSN 0171-2004 Series E-ISSN 1865-0325

Glutinous

誹謗

constitutional

Book 2021earch in disciplines, such as molecular medicine, physiology, and pathophysiology. Today the research on human-based test systems has gained major interest and funding in the EU and the US has increased over the last years. Moreover, so-called 3R (reduce, replace, refine animal experiments) centres have been established worldwide.?.

Nebulous

菊花

DAMP

978-3-030-70065-2Springer Nature Switzerland AG 2021

mendacity

Organotypic Models in Drug Development978-3-030-70063-8Series ISSN 0171-2004 Series E-ISSN 1865-0325